July 22, 2014

Miami-Dade Business Profile

Biscayne Pharmaceuticals

| 8/14/2013
Samuel Reich and Andrew Schally (sitting)
Samuel Reich (standing) and Andrew Schally

For more than half a century, Nobel Prize-winning scientist and University of Miami faculty member Andrew Schally has been researching the hormones that stimulate growth in the body’s tissues. Now his work is being used by Miami-based Biscayne Pharmaceuticals, which was founded last year and licensed from UM the rights to Schally’s inventions related to that research. The company, which Schally works with as scientific adviser, is using his discovery to develop possible treatments for cancer and heart disease.

Biscayne Pharma got going after a $1.5-million investment from its co-founders and Miami Beach investment firm Reich Group, whose Managing Partner Samuel Reich joined Biscayne Pharma as CEO. “This is a breakthrough that will really transform the way we treat cancer,” Reich says.

Tags: Miami-Dade, Healthcare, Technology/Innovation

Digital Access

DIRECT DIGITAL ACCESS
Add digital to your current subscription, purchase a single ditgital issue, or start a new subscription to Florida Trend.

TABLE OF CONTENTS
An overview of the features and articles in this month's issue of Florida Trend.

ACCESS THIS ISSUE »

Florida Business News

Florida Trend Video Pick

Greenlight Pinellas: Connecting Tampa Bay
Greenlight Pinellas: Connecting Tampa Bay

Chris Steinocher, President & CEO, St. Petersburg Area Chamber of Commerce, explains the benefits of a proposed public mass transit system with plans to unite the Tampa Bay Area.

Earlier Videos | Viewpoints@FloridaTrend

Ballot Box

Do you agree with the Florida jury who just awarded $23 billion to the wife of a (deceased) smoker in her suit against RJ Reynolds?

  • Yes, justice has been served
  • No, that is too much

See Results

Ballot Box
Subscribe